Axial Therapeutics Releases New Preclinical Data from AB-2004 Program Demonstrating Reduction of Microbiome-Derived Metabolites in Mouse Models with Autism Spectrum Disorder Axial Biotherapeutics: May 2, 2019 Read More
Go back to Press Page
